The role of managed care pharmacy in coprescribing naloxone for patients with specific risk: recommendations from the AMCP Addiction Advisory Group

Prescription opioid misuse remains a significant cause of morbidity and mortality associated with drug overdose. Researchers, government agencies, public health interests, and professional organizations support the benefits of naloxone coprescribing for patients on chronic opioid therapy to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Skelton, Jann B, Dharbhamalla, Vyishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372947/
https://www.ncbi.nlm.nih.gov/pubmed/34949114
http://dx.doi.org/10.18553/jmcp.2022.28.1.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372947/
https://www.ncbi.nlm.nih.gov/pubmed/34949114
http://dx.doi.org/10.18553/jmcp.2022.28.1.100

Ejemplares similares